The multiple benefits of second-generation β-lactamase inhibitors in treatment of multidrug-resistant bacteria

2021/01/18 by F. de Sousa Coelho, Jean‐Luc Mainardi, J.-L. Mainardi · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Antibiotic Resistance in Bacteria #Antibiotic resistance #Antibiotics #Antibiotics Pharmacokinetics and Efficacy #Bacteria #Biology #Genetics #Microbiology #Pneumocystis jirovecii pneumonia detection and treatment #Sulbactam #Tazobactam

paper · doi:10.1016/j.idnow.2020.11.007

openalex publication_date 2021/01/18 · crossref created 2021/01/18 · crossref issued 2021/09/01 · crossref published 2021/09/01 · crossref published-print 2021/09/01 · openalex created_date 2025/10/10 · crossref deposited 2025/11/13 · crossref indexed 2026/05/16 · openalex updated_date 2026/07/28

Citations

• Three Decades of β-Lactamase Inhibitors
• IRT and CMT β-lactamases and inhibitor resistance
• beta-Lactamases in laboratory and clinical resistance
• Mechanisms of Antibiotic Resistance
• Porins and small-molecule translocation across the outer membrane of Gram-negative bacteria

Cited by

• History of penicillin [wikipedia]